Large-scale testing (Phase 3)UnknownNCT00006049What this trial is testingZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung CancerWho this might be right forLung Cancer AstraZeneca
Post-approval studies (Phase 4)Study completedNCT00608868What this trial is testingSELINE: Second-Line Iressa Phase IV Study in NSCLC PatientsWho this might be right forNon Small Cell Lung Carcinoma AstraZeneca 156
Testing effectiveness (Phase 2)Study completedNCT00088088What this trial is testingSTA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)Who this might be right forStage IIIB Non-Small Cell Lung CancerStage IV Non-Small Cell Lung Cancer Synta Pharmaceuticals Corp. 86
Large-scale testing (Phase 3)Looking for participantsNCT06674343What this trial is testingFurmonertinib 160mg as First-line Treatment in Locally Advanced or Metastatic NSCLC With EGFR Classical MutationsWho this might be right forAdvanced or Metastatic Non-small Cell Lung Cancer Peking Union Medical College Hospital 144
Early research (Phase 1)Ended earlyNCT00511576What this trial is testingStudy to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer TumorsWho this might be right forBreast CancerLung CancerPulmonary Cancer+5 more Mirati Therapeutics Inc. 54
Not applicableStudy completedNCT01138358What this trial is testingStudy of Episodic Breathlessness in Patients With Lung Cancer or Other Advanced DiseaseWho this might be right forDyspneaLung CancerMetastatic Cancer King's College Hospital NHS Trust 50
Testing effectiveness (Phase 2)Ended earlyNCT01471197What this trial is testingSafety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung CancerWho this might be right forLung Cancer - Non Small Cell Bristol-Myers Squibb 9
Testing effectiveness (Phase 2)WithdrawnNCT02735850What this trial is testingCombination of SABR and L19-IL2 in Patients With Stage IV Lung Cancer (ImmunoSABR)Who this might be right forNSCLC Stage IVLimited Metastatic Disease Maastricht Radiation Oncology
Large-scale testing (Phase 3)Active Not RecruitingNCT05499390What this trial is testingAK112 in Advanced Non-Small Cell Lung CancerWho this might be right forAdvanced Non-small-cell Lung Cancer Akeso 398
Not applicableStudy completedNCT00068497What this trial is testingGefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerWho this might be right forAnaplastic Thyroid CancerInsular Thyroid CancerMetastatic Parathyroid Cancer+83 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04036682What this trial is testingA Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung CancerEGFR Exon 20 Mutation Cullinan Therapeutics Inc. 284
Early research (Phase 1)Study completedNCT00005023What this trial is testingVaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV CancerWho this might be right forBreast CancerLung CancerOvarian Cancer University of Washington
Testing effectiveness (Phase 2)Looking for participantsNCT05351788What this trial is testingSKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.Who this might be right forNon-small Cell Lung Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT03965689What this trial is testingTesting the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With ImmunotherapyWho this might be right forMetastatic Lung Non-Small Cell Squamous CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8+5 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06518057What this trial is testingHippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+2 more University of Washington 22
Large-scale testing (Phase 3)Ended earlyNCT02187367What this trial is testingSafety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC PatientsWho this might be right forCarcinoma, Non-Small-Cell Lung Bioven Europe 106
Early research (Phase 1)Study completedNCT00510445What this trial is testingStudy of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung CancerWho this might be right forLung Cancer Geron Corporation 27
Testing effectiveness (Phase 2)Ended earlyNCT02204345What this trial is testingA Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous HistologyWho this might be right forSquamous Non-Small Cell Lung Cancer Hoffmann-La Roche 12
Testing effectiveness (Phase 2)Study completedNCT03847519What this trial is testingStudy of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung CancerWho this might be right forLung Cancer, Non-Small CellMetastatic Squamous Cell CarcinomaMetastatic Non-Squamous Cell Carcinoma Advaxis, Inc. 24
Large-scale testing (Phase 3)Study completedNCT04676412What this trial is testingEfficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) [MK-7902-007/E7080-G000-314/LEAP-007] - China Extension StudyWho this might be right forNon-small Cell Lung Cancer Merck Sharp & Dohme LLC 107